John J Sheehan
Overview
Explore the profile of John J Sheehan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
905
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antozzi C, Vu T, Ramchandren S, Nowak R, Farmakidis C, Bril V, et al.
Lancet Neurol
. 2025 Jan;
24(2):105-116.
PMID: 39862879
Background: Given burdensome side-effects and long latency for efficacy with conventional agents, there is a continued need for generalised myasthenia gravis treatments that are safe and provide consistently sustained, long-term...
2.
Reed Johnson F, Sheehan J, Ozdemir S, Wallace M, Yang J
Pharmacoeconomics
. 2024 Oct;
43(1):45-52.
PMID: 39367175
Objectives: This study was designed to test hypotheses regarding the path dependence of health-outcome values in the form of linear additivity of health-state utilities and diminishing marginal utility of health...
3.
Le H, Ken-Opurum J, LaPrade A, Maculaitis M, Sheehan J
BMC Neurol
. 2024 Jan;
24(1):51.
PMID: 38297247
Background: This retrospective study examined the humanistic burden of fatigue in patients with relapsing-remitting multiple sclerosis (RRMS), compared with adults without MS, using data from the 2017 and 2019 US...
4.
Sheehan J, LaVallee C, Maughn K, Balakrishnan S, Pesa J, Joshi K, et al.
J Comp Eff Res
. 2023 Nov;
13(1):e230091.
PMID: 37987716
Major depressive disorder (MDD) is a debilitating illness in which depressive symptoms may persist after treatment. Treatment inertia is the continued use of the same pharmacotherapy regimen when treatment goals...
5.
Reed Johnson F, Gonzalez J, Sheehan J, Reed S
Pharmacoeconomics
. 2023 May;
41(8):845-856.
PMID: 37133682
While the quality-adjusted life-year construct has advantages of simplicity and consistency, simplicity requires strong assumptions. In particular, standard assumptions result in health-state utility functions that are unrealistically linear and separable...
6.
Turkoz I, Nelson J, Wilkinson S, Borentain S, Macaluso M, Trivedi M, et al.
Psychiatry Res
. 2023 Apr;
323:115165.
PMID: 37019044
This exploratory post hoc analysis of two pooled 4-week, phase 3, double-blind, placebo- and active-controlled studies that compared esketamine nasal spray plus a newly initiated oral antidepressant (ESK+AD; n = ...
7.
Lin J, Szukis H, Sheehan J, Alphs L, Menges B, Lingohr-Smith M, et al.
Psychiatr Res Clin Pract
. 2022 Sep;
1(2):68-76.
PMID: 36101876
Objectives: This study aimed to evaluate hospital length of stay (LOS) and cost as well as readmission risk and the associated economic burden among patients hospitalized for treatment-resistant and non-treatment-resistant...
8.
Le H, Ken-Opurum J, LaPrade A, Maculaitis M, Sheehan J
Mult Scler Relat Disord
. 2022 Jul;
65:103971.
PMID: 35843012
Background: Fatigue, a common disabling symptom in multiple sclerosis (MS), is reported by the majority of patients. However, evidence on the economic burden of fatigue in MS by fatigue status...
9.
Zhdanava M, Voelker J, Pilon D, Joshi K, Morrison L, Sheehan J, et al.
J Affect Disord
. 2022 May;
311:303-310.
PMID: 35597466
Background: This study assessed the healthcare resource utilization (HRU) and cost burden of patients with major depressive disorder (MDD) and acute suicidal ideation or behavior (SIB; MDSI) versus those with...
10.
Pilon D, Neslusan C, Zhdanava M, Sheehan J, Joshi K, Morrison L, et al.
J Clin Psychiatry
. 2022 Apr;
83(3).
PMID: 35390231
Suicidal ideation or behavior (SIB) is a symptom of major depressive disorder (MDD). This study evaluated health care resource utilization (HRU) and costs of commercially insured adults who had diagnosed...